Nutex Health Inc.
NUTX
$176.53
$0.060.03%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 730.73% | -2,953.30% | 4,120.33% | 294.87% | -58.58% |
| Total Depreciation and Amortization | 0.62% | 15.77% | 21.64% | 12.77% | 4.76% |
| Total Amortization of Deferred Charges | 11.50% | 17.29% | -30.68% | 667.78% | -24.31% |
| Total Other Non-Cash Items | 626.27% | 1,883.45% | 2,336.57% | 33.24% | 1,410.92% |
| Change in Net Operating Assets | -4,414.40% | -1,939.27% | -2,006.28% | -1,719.86% | -156.26% |
| Cash from Operations | 1,366.03% | 105.56% | 1,570.44% | 103.01% | 244.87% |
| Capital Expenditure | 51.05% | -391.06% | 91.27% | -147.86% | 78.54% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -13.11% | 115.43% | 91.27% | -485.40% | 92.62% |
| Total Debt Issued | -85.42% | -60.46% | 37.94% | -71.89% | 141.81% |
| Total Debt Repaid | -120.63% | -128.66% | 41.71% | 20.90% | 18.55% |
| Issuance of Common Stock | -94.93% | -19.60% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -1,430.98% | -- | -- |
| Other Financing Activities | -1,202.06% | -908.38% | -- | -216.12% | -8.96% |
| Cash from Financing | -7,001.43% | -1,200.42% | -219.80% | 23.71% | 90.16% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,036.31% | 11.13% | 450.84% | -29.93% | 202.91% |